A carregar...
Publicação
Bausch + lomb company - valuing operational synergies
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 992.84 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This work project conducts a comprehensive company valuation of Bausch + Lomb,
while exploring various exit strategies. The group portion of this work involves the use of
discounted cash flow (DCF) and relative valuation approaches to estimate the value of Bausch
+ Lomb. Based on the DCF model, the enterprise value of Bausch + Lomb is determined to be
$7,325 mn as of December 31, 2021. An assessment of operational synergies is carried out,
which reveals that Bausch + Lomb could be valued at $9,427 mn in a strategic acquisition
scenario, with synergies having a present value of $2,039 mn
Descrição
Palavras-chave
Bausch + lomb Company valuation Acquisition Pharmaceuticals Eye Care